NFE2L2 and COVID-19: Nrf2 was unaffected in COVID-19/B.1 variant but increased in COVID-19/B.1.1.7 variant (Figure 1; p < 0.0001 vs. COVID-19/B.1 patients), whilst NOX4 was upregulated in both COVID-19 variants.